The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model

被引:17
作者
Bahassi, El Mustapha
Penner, C. Gail
Robbins, Susan B.
Tichy, Elisia
Feliciano, Estrella
Yin, Moying
Liang, Li
Deng, Li
Tischfield, Jay A.
Stambrook, Peter J.
机构
[1] Univ Cincinnati, Coll Med, Dept Cell & Canc Biol Neurobiol & Anat, Cincinnati, OH 45267 USA
[2] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA
关键词
CHEK2; breast cancer; DNA damage; mouse model; genomic instability;
D O I
10.1016/j.mrfmmm.2006.11.025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Allelic variants of CHEK2 contribute to an elevated risk for human breast cancer and possibly other cancer types. In particular, the CHEK2*1100delC polymorphic variant has been identified as a low-penetrance breast cancer susceptibility allele in breast cancer families with wild type BRCA1 and BRCA2. To better understand the molecular basis by which this allele increases risk for disease, we have generated a mouse in which the wild type CHEK2 (Chk2 in mouse) allele has been replaced with the 1100delC variant. Mouse embryo fibroblasts (MEFs) derived from these mice have an altered cell cycle profile in which a far greater proportion of cells are in S-phase and in G2 (4N) compared with wild type cells. The mutant cells show signs of spontaneous genomic instability as indicated by polyploidy and an increase in DNA double strand breaks. (c) 2006 Published by Elsevier B.V.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 45 条
[11]   Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant [J].
de Bock, GH ;
Schutte, M ;
Krol-Warmerdam, EMM ;
Seynaeve, C ;
Blom, J ;
Brekelmans, CTM ;
Meijers-Heijboer, H ;
van Asperen, CJ ;
Cornelisse, CJ ;
Devilee, P ;
Tollenaar, RAEM ;
Klijn, JGM .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (10) :731-735
[12]   Mutations in CHEK2 associated with prostate cancer risk [J].
Dong, XY ;
Wang, L ;
Taniguchi, K ;
Wang, XS ;
Cunningham, JM ;
McDonnell, SK ;
Qian, CP ;
Marks, AF ;
Slager, SL ;
Peterson, BJ ;
Smith, BI ;
Cheville, JC ;
Blute, ML ;
Jacobsen, SJ ;
Schaid, DJ ;
Tindall, DJ ;
Thibodeau, SN ;
Liu, WG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) :270-280
[13]   Limited relevance of the CHEK2 gene in hereditary breast cancer [J].
Dufault, MR ;
Betz, B ;
Wappenschmidt, B ;
Hofmann, W ;
Bandick, K ;
Golla, A ;
Pietschmann, A ;
Nestle-Krämling, C ;
Rhiem, K ;
Hüttner, C ;
Von Lindern, C ;
Dall, P ;
Kiechle, M ;
Untch, M ;
Jonat, W ;
Meindl, A ;
Scherneck, S ;
Niederacher, D ;
Schmutzler, RK ;
Arnold, N .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (03) :320-325
[14]  
Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251
[15]   The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis [J].
Falck, J ;
Mailand, N ;
Syljuåsen, RG ;
Bartek, J ;
Lukas, J .
NATURE, 2001, 410 (6830) :842-847
[16]   Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women [J].
Friedrichsen, DM ;
Malone, KE ;
Doody, DR ;
Daling, JR ;
Ostrander, EA .
BREAST CANCER RESEARCH, 2004, 6 (06) :R629-R635
[17]   Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner [J].
Hirao, A ;
Cheung, A ;
Duncan, G ;
Girard, PM ;
Elia, AJ ;
Wakeham, A ;
Okada, H ;
Sarkissian, T ;
Wong, JA ;
Sakai, T ;
de Stanchina, E ;
Bristow, RG ;
Suda, T ;
Lowe, SW ;
Jeggo, PA ;
Elledge, SJ ;
Mak, TW .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (18) :6521-6532
[18]   Nonsense-mediated decay approaches the clinic [J].
Holbrook, JA ;
Neu-Yilik, G ;
Hentze, MW ;
Kulozik, AE .
NATURE GENETICS, 2004, 36 (08) :801-808
[19]   Mutation analysis of the CHK2 gene in breast carcinoma and other cancers [J].
Ingvarsson, S ;
Sigbjornsdottir, BI ;
Chen, HP ;
Hafsteinsdottir, SH ;
Ragnarsson, G ;
Barkardottir, RB ;
Arason, A ;
Egilsson, V ;
Bergthorsson, JT .
BREAST CANCER RESEARCH, 2002, 4 (03)
[20]   Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response [J].
Jack, MT ;
Woo, RA ;
Hirao, A ;
Cheung, A ;
Mak, TW ;
Lee, PWK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9825-9829